Deutsche Bank
ALXO icon

Deutsche Bank’s ALX Oncology ALXO Stock Holding History

Deutsche Bank’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+107,428
New +$192K ﹤0.01% 3196
2025
Q2 		– Sell
-101,113
Closed -$62.7K – 3609
2025
Q1 		$62.7K Hold
101,113
– – ﹤0.01% 3332
2024
Q4 		$169K Buy
101,113
+84,830
+521% +$130K ﹤0.01% 3141
2024
Q3 		$29.6K Buy
16,283
+5,849
+56% +$21.7K ﹤0.01% 3434
2024
Q2 		$62.9K Sell
10,434
-1,054
-9% -$13K ﹤0.01% 3271
2024
Q1 		$128K Buy
11,488
+366
+3% +$5.14K ﹤0.01% 3050
2023
Q4 		$166K Buy
11,122
+333
+3% +$3.16K ﹤0.01% 2976
2023
Q3 		$51.8K Sell
10,789
-182,686
-94% -$991K ﹤0.01% 3404
2023
Q2 		$1.45M Sell
193,475
-153,314
-44% -$1M ﹤0.01% 1780
2023
Q1 		$1.57M Buy
346,789
+4,434
+1% +$33.6K ﹤0.01% 1825
2022
Q4 		$3.86M Buy
342,355
+142
+0% +$1.59K ﹤0.01% 1324
2022
Q3 		$3.27M Buy
342,213
+394
+0.1% +$4.59K ﹤0.01% 1388
2022
Q2 		$2.77M Sell
341,819
-1,844
-0.5% -$20.1K ﹤0.01% 1587
2022
Q1 		$5.81M Buy
343,663
+332,243
+2,909% +$5.67M ﹤0.01% 1337
2021
Q4 		$245K Sell
11,420
-4,203
-27% -$181K ﹤0.01% 3277
2021
Q3 		$1.15M Buy
15,623
+4,360
+39% +$291K ﹤0.01% 2520
2021
Q2 		$616K Sell
11,263
-345
-3% -$20.6K ﹤0.01% 3082
2021
Q1 		$855K Buy
11,608
+4,476
+63% +$352K ﹤0.01% 2758
2020
Q4 		$615K Buy
7,132
+2,024
+40% +$122K ﹤0.01% 2761
2020
Q3 		$193K Buy
+5,108
New +$201K ﹤0.01% 3234

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Deutsche Bank's ALXO Position: Q2 2026 in Review

Deutsche Bank opened a new position in ALX Oncology (ALXO) in Q2 2026: 107,428 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #3196 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in ALXO as recently as Q1 2025.

Deutsche Bank first reported a position in ALXO in Q3 2020 and has held it in 20 quarters since. The position peaked at $5.81M in Q1 2022. 94 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Deutsche Bank held 107,428 shares of ALX Oncology worth $222K as of Q2 2026.
  • ALX Oncology was a new Deutsche Bank position in Q2 2026.
  • ALX Oncology made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3196 holding.
  • Deutsche Bank first reported a position in ALX Oncology in Q3 2020 and has held it in 20 quarters since.
  • Deutsche Bank's ALX Oncology position peaked at $5.81M in Q1 2022.
  • 94 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.